1. Protein-binding assays have been used to measure plasma 1,25-dihydroxy-vitamin D 1,25-(OH),Dl as well as 25-hydroxy-vitamin D [25-(OH)D1 in rats given 10 mg of phosphorus (P) day-' kg-' as ethane-1-hydroxy-1,l-diphosphonate (EHDP).
Introduction
In recent years diphosphonates have been recognized to be useful therapeutic agents in the management of certain disorders of bone metabolism, especially in Paget's disease [ 1-31. Diphosphonates are potent inhibitors of the formation and dissolution of calcium phosphate crystals in vitro [4, 51 and of bone resorption in vivo [4] . One of the compounds, ethane-lhydroxy-1,Ldiphosphonate (EHDP), when given in large doses to animals, has been shown to inhibit bone mineralization [6-91 and to decrease the intestinal absorption of calcium [7, 
Methods

Animal experiments
The experiments were performed with male Wistar rats bred in this institute. EHDP (kindly provided by Procter and Gamble Co., Cincinnati, OH, U.S.A.) was dissolved in distilled water, the solution adjusted to pH 7.4 with NaOH and injected subcutaneously (s.c.) at a dose of 10 mg of P day-' kg-' in a volume of 2 ml/kg body wt. Vitamin D, supplements were given orally in 0.1 ml of arachis oil. Blood for the determination of vitamin D metabolites was obtained by aortic puncture 24 h after the last injection of EHDP. The animals were anaesthetized with an intraperitoneal (i.p.) injection of 30-40 mg of pentobarbital sodium (Nembutal; Abbott Laboratories, North Chicago, IL, U.S.A.)/kg. Heparin (kindly provided by F. Hoffmann-La Roche and Co., Basle) was used to prevent coagulation and plasma obtained by centrifugation was frozen and kept at -2OOC until analyses of vitamin D metabolites.
Time-course of effect of EHDP on plasma
25-(0H)D and 1,25-(OH)2D
Rats weighing 191 f 14 g (mean k SD) were given a commercial diet containing 0.9% Ca/ 0.7% P and 39 nmol of vitamin D,/kg ad libitum. They were treated with EHDP for 1, 2, 3, 4 or 7 days. Controls received an equivalent volume of NaCl solution (150 mmol/l: saline) for either 1 or 7 days.
Influence of dietary Ca and P on the effect of EHDP on plasma 1,25-(OH),D 15 g (mean f SD) were given one of three diets containing either 1.0%
Rats weighing 180
Ca/l.O% P, 1.0% Ca/0.2% P or 0.2% Ca/l.O% P for 2 weeks ad libitum. The diets were made by adding calcium gluconate and a mixture of K,HPO,/KH,PO, (3:7) to a diet containing 0.14% Ca/O.22% P (Altromin C-1034, Altromin GmbH, Lage, West Germany). Since the diet was vitamin D-poor the rats were supplemented with 1 5 nmol of vitamin D, every 2 days. After a 7 day equilibration period the animals were treated with EHDP for 7 days. Control animals received an equivalent volume of saline. The diet during EHDP-treatment was the same as the one given during the equilibration period. 
Results
Time-course of the effect of EHDP on plasma 25-(0H)D and 1,25-(OH),D
As shown in Fig. 1 , EHDP at a dose of 10 mg of P day-' kg-l, during the first 3 days of treatment, produced a progressive decrease of plasma 25-(0H)D which then remained constant for the rest of the experimental period. Plasma 1,25-(OH),D was already decreased after 1 day of treatment and fell to values below 50 pmol/l thereafter. When the limit of detection of plasma 1,25-(OH),D in the assay was decreased to 13 pmol/l by pooling plasma of EHDP-treated rats, plasma 1,25-(OH),D was found to be 32 pmol/l on day 4 and 20 pmol/l on day 7 (means of two plasma pools for each day from groups of six rats). Table 1 below those observed in control animals on a high-Ca/high-P diet.
Influence of dietary Ca and P on the effect of EHDP on plasma 1,25-(OH),D
Influence of vitamin D intake on the effect of EHDP on plasma 25-(0H)D and 1,25-(OH),D
The results of two separate experiments are presented in Table 2 . Plasma 25-(0H)D increased with increasing supply of vitamin D both in control and in EHDP-treated animals. EHDP produced a decrease of plasma 25-(0H)D in animals receiving 0.6 or 6.5 nmol of vitamin D,/day, but had no effect on this in animals given 65 nmol of vitamin D,/day. In control rats increasing dietary vitamin D, to 65 nmol/day produced a decrease of plasma 1,25-(OH),D. EHDP-treated animals responded to a supplementation with 65 nmol of vitamin D,/day with an increase of plasma 1,25-(OH),D to a level equal to that of corresponding control animals.
Discussion
Our results demonstrate that the circulating levels of 1,25-(OH),D can be decreased to very low values with large doses of EHDP in rats maintained on ordinary, vitamin D-containing, laboratory food. This finding is important when considering previous investigations in which EHDP was used as a tool to produce 1,25- The well known stimulatory effect of a low-Ca or a low-P diet on plasma 1,25-(OH),D in rats [25] , which was observed in the control animals, was also present in EHDP-treated rats, although in all the groups EHDP-treated rats had much lower plasma 1,25-(OH),D than corresponding control animals. These results show that the homeostatic mechanisms which mediate the response of plasma 1,25-(OH),D to dietary Ca or P restriction are at least partially operative in EHDP-treated rats. This should be considered when EHDP is used to produce 1,25-(OH),D deficiency in experiments involving low-mineral diets.
We can only speculate about the mechanism by which EHDP influences plasma 1,25-(OH),D. 
